Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of Autophagy by Sorafenib: Effects on Treatment Response
Néstor Prieto‐Domínguez, Raquel Ordóñez, Ana María Cameán Fernández, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Autophagy in liver diseases: Time for translation?
Manon Allaire, Pierre‐Emmanuel Rautou, Patrice Codogno, et al.
Journal of Hepatology (2019) Vol. 70, Iss. 5, pp. 985-998
Open Access | Times Cited: 327
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
Carolina Méndez‐Blanco, Flavia Fondevila, Andrés García‐Palomo, et al.
Experimental & Molecular Medicine (2018) Vol. 50, Iss. 10, pp. 1-9
Open Access | Times Cited: 278
LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
Weidong Li, Xuesong Dong, Changjun He, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 167
Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management
Yingmei Zhang, Adam Whaley‐Connell, James R. Sowers, et al.
Pharmacology & Therapeutics (2018) Vol. 191, pp. 1-22
Open Access | Times Cited: 102
PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib
Kai Zhang, Jing Chen, Hao Zhou, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 3
Open Access | Times Cited: 99
Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma
Mengxi Huang, Cheng Chen, Jian Geng, et al.
Cancer Letters (2017) Vol. 398, pp. 12-21
Closed Access | Times Cited: 98
Autophagy in Cancer Therapy
Simone Fulda
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 96
Autophagy: Dual Response in the Development of Hepatocellular Carcinoma
Hamza O. Yazdani, Hai Huang, Allan Tsung
Cells (2019) Vol. 8, Iss. 2, pp. 91-91
Open Access | Times Cited: 83
Sophflarine A, a novel matrine-derived alkaloid from Sophora flavescens with therapeutic potential for non-small cell lung cancer through ROS-mediated pyroptosis and autophagy
Ding Luo, Xiaoyong Dai, He Tian, et al.
Phytomedicine (2023) Vol. 116, pp. 154909-154909
Closed Access | Times Cited: 30
Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
Ruifan Ye, Ninggao Dai, Qikuan He, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 105, pp. 962-973
Closed Access | Times Cited: 80
Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury
Sofie Martens, Manhyung Jeong, Wulf Tonnus, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 6, pp. e2904-e2904
Open Access | Times Cited: 77
Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles
Pengxuan Zhao, Minsi Li, Yao Wang, et al.
Acta Biomaterialia (2018) Vol. 72, pp. 248-255
Closed Access | Times Cited: 75
Apigetrin induces extrinsic apoptosis, autophagy and G2/M phase cell cycle arrest through PI3K/AKT/mTOR pathway in AGS human gastric cancer cell
Seong Min Kim, Preethi Vetrivel, Sang Eun Ha, et al.
The Journal of Nutritional Biochemistry (2020) Vol. 83, pp. 108427-108427
Closed Access | Times Cited: 68
Is the era of sorafenib over? A review of the literature
Guanghan Fan, Xuyong Wei, Xiao Xu
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 66
Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy
Jun Li, Peng-Wen Wu, Yuan Zhou, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 61
Autophagy in cancer: a complex relationship
Lindsay Wilde, Katherina Tanson, Joseph Curry, et al.
Biochemical Journal (2018) Vol. 475, Iss. 11, pp. 1939-1954
Closed Access | Times Cited: 61
Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer
María Hernández, Patricia de la Cruz‐Ojeda, Ma José López-Grueso, et al.
Redox Biology (2020) Vol. 36, pp. 101510-101510
Open Access | Times Cited: 55
Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells
Pei‐Ming Yang, Li-Shan Lin, Tsang-Pai Liu
Biomolecules (2020) Vol. 10, Iss. 1, pp. 117-117
Open Access | Times Cited: 54
Autophagy in liver diseases
Elias Kouroumalis, Argryro Voumvouraki, Aikaterini Augoustaki, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 1, pp. 6-65
Open Access | Times Cited: 52
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
Xinchen Tian, Tinghao Yan, Fen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Camptothecin Sensitizes Hepatocellular Carcinoma Cells to Sorafenib- Induced Ferroptosis Via Suppression of Nrf2
Ahmed S. Elkateb, Shahira Nofal, Sahar A. Ali, et al.
Inflammation (2023) Vol. 46, Iss. 4, pp. 1493-1511
Open Access | Times Cited: 19
Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells
María Hernández, Raúl González, Ángel J. de la Rosa, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 1, pp. 692-708
Open Access | Times Cited: 55
Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma.
Jiyao Sheng, Hanjiao Qin, Kun Zhang, et al.
PubMed (2018) Vol. 8, Iss. 3, pp. 354-365
Closed Access | Times Cited: 51
Vascular mimicry: changing the therapeutic paradigms in cancer
Nazila Fathi Maroufi, Sina Taefehshokr, Mohammad‐Reza Rashidi, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 6, pp. 4749-4765
Closed Access | Times Cited: 46
Acetylsalicylic acid and salicylic acid present anticancer properties against melanoma by promoting nitric oxide-dependent endoplasmic reticulum stress and apoptosis
Priscila Ausina, Jéssica Ristow Branco, Thainá M. Demaria, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top